Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 1582

DALLAS, TX 75231

Study Summary:

A multi-center, randomized, open-label, active controlled, parallel arm study to compare the efficacy of 12 weeks of treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as add-on therapy in patients with Type 2 Diabetes inadequately controlled with Metformin Montherapy in a community-based setting.

Qualified Participants Must:

• Be 18 to 80 years of age
• Be male, non-fertile female or female of childbearing potential using a medically approved birth control method
• Be a patient who has received a stable dose of Metformin of at least 1,000 mg/day for four weeks prior to their first visit
• Have a body mass index of 22-40 kg/m2
• Have uncontrolled fasting sugars
• Have the ability to comply with all study requirements

Qualified Participants May Receive:

Free glucometer with supplies throughout the study, free study medication or alternate medication for 10 weeks, and free labwork and office visits.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.